Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Dermata Therapeutics Inc. (DRMAW)

  • Technical Exchange News
  • April 01, 2025, 18:35 UTC
  • 18

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Aptose Biosciences Inc (APTO)

  • Technical Exchange News
  • April 01, 2025, 18:35 UTC
  • 17

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

FORESIGHT (FRSX)

  • Technical Exchange News
  • April 01, 2025, 04:25 UTC
  • 20

FORESIGHT (FRSX) was added to the list of traded instruments on TASE exchange

Comment Full text

Connect Biopharma Holdings Ltd (CNTB)

  • Technical Exchange News
  • April 01, 2025, 03:03 UTC
  • 17

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

CNS Pharmaceuticals Inc. (CNSP)

  • Technical Exchange News
  • April 01, 2025, 03:03 UTC
  • 19

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Biodesix Inc (BDSX)

  • Technical Exchange News
  • April 01, 2025, 03:03 UTC
  • 20

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Connect Biopharma Holdings Ltd (CNTB)

  • Technical Exchange News
  • March 31, 2025, 20:04 UTC
  • 16

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

CNS Pharmaceuticals Inc. (CNSP)

  • Technical Exchange News
  • March 31, 2025, 20:04 UTC
  • 17

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Biodesix Inc (BDSX)

  • Technical Exchange News
  • March 31, 2025, 20:04 UTC
  • 15

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

23andMe Inc (ME)

  • Technical Exchange News
  • March 31, 2025, 07:49 UTC
  • 18

23andMe Inc (ME) was removed from the list of traded instruments on NASDAQ exchange

Comment Full text
  • Previous
  • 77
  • 78
  • 79
  • 80
  • 81
  • Next

Search

News categories

  • Technical Exchange News(9514)
  • Event(407)
  • SEC News(156013)
  • FDA Approval(8914)
  • Company Report(721)
  • Business News(105880)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin